>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Monday 06 July 2026
08:30 - 09:30
Session 01: Keynote session
Monday 06 July 2026
08:30 - 09:30: Session 01: Keynote session:
Kirstine Kirkegaard, Denmark
Chris Barratt, United Kingdom
08:30 - 09:00
HR Keynote lecture: Forty years of Human Reproduction: building evidence, challenging practice, raising standards
Chris Barratt, United Kingdom
Kirstine Kirkegaard, Denmark
09:00 - 09:30
Theory of evolution of human infertility
Hans Ivar Hanevik, Norway
09:00 - 12:00
Practising embryo transfer techniques using a virtual reality-based simulator - Hands-on course only for those participants registered for this course
09:00 - 12:00: Practising embryo transfer techniques using a virtual reality-based simulator - Hands-on course only for those participants registered for this course:
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
10:00 - 11:30
Session 02: Repairing life's first steps
10:00 - 11:30: Session 02: Repairing life's first steps:
Roger Sturmey, United Kingdom
10:00 - 10:15
Restoring Shugoshin-1 prevents chromosomal errors in ageing human oocytes
10:15 - 10:30
Why human zygotes that form morphologically bipolar spindles during the first mitosis multinucleate: linking low spindle AR, metaphase plate spread, and late-anaphase dispersion
10:30 - 10:45
Boosting Oocyte Rescue: Nicotinamide Mononucleotide (NMN) Restores the Competence of Poor-Prognosis GV Oocytes in Aged Women
Cristina Rodríguez Varela, Spain
10:45 - 11:00
Attenuation of mosaic aneuploidy and erroneous first mitotic division of human embryos
Aleksandra Byrska, United Kingdom
11:00 - 11:15
Robust non-invasive human oocyte maturation and age classification through METAPHOR metabolic imaging and five biochemical–organelle biomarkers
11:15 - 11:30
Human cumulus cell-derived miRNAs regulate pathways underlying oocyte maturation and developmental competence
10:00 - 11:30
Session 03: What is new in PCOS?
10:00 - 11:30: Session 03: What is new in PCOS?:
Chairperson to be announced
Roy Homburg, United Kingdom
10:00 - 10:15
Glucagon-like peptide-1 receptor agonists (GLP-1’s) for the improvement of cardiometabolic outcomes in women with polycystic ovarian syndrome (PCOS): a systematic review and network meta-analysis (NMA)
Zachary Nash, United Kingdom
10:15 - 10:30
Metabolomic profiling of Polycystic Ovary Syndrome (PCOS): insights from the UK Biobank
10:30 - 10:45
Impaired uterine developmental programming in PCOS: impact of reduced dimensions and morphological anomalies on ART pregnancy loss
10:45 - 11:00
Extended letrozole protocol versus letrozole-inositol combination for ovulation induction in letrozole-resistant polycystic ovary syndrome women
11:00 - 11:15
Inositol supplementation in polycystic ovary syndrome (PCOS): a systematic review of randomised controlled trial focusing on data integrity.
11:15 - 11:30
Letrozole versus clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome (LOCI): a multicentre, 2x2 factorial design, randomised controlled trial
Pedro Melo, United Kingdom
10:00 - 11:30
Session 04: Trials and RCTs in implantation and early pregnancy
10:00 - 11:30: Session 04: Trials and RCTs in implantation and early pregnancy:
Chairperson to be announced
10:00 - 10:15
Multivariable biomarker models for the prediction of miscarriage in pregnancy of uncertain viability
Margot Pikovsky, United Kingdom
10:15 - 10:30
Effect of Vaginal Lactobacillus Capsule (Lactobacillus delbrueckiiDM8909) on FET outcomes in PCOS women with vaginal dysbacteriosis: a multicentre, open-label, randomised controlled trial
10:30 - 10:45
Pre-conception and first trimester metformin on miscarriage risk in women with polycystic ovary syndrome: a randomised, placebo-controlled trial
Adam Devall, United Kingdom
10:45 - 11:00
Effect of natural versus programmed cycle on the risk of hypertensive disorders of pregnancy following frozen-thawed blastocyst transfer: a randomized clinical trial in ovulatory women
11:00 - 11:15
Adenomyosis and pregnancy outcomes in women undergoing assisted reproductive technology (ART): a prospective multicentre cohort study (AdAPT-ART)
Ishita Mishra, United Kingdom
11:15 - 11:30
Advanced maternal age independently affects live birth and increases miscarriage risk in donor oocyte cycles
10:00 - 11:30
Session 05: Impact of sperm function on reproductive outcome
10:00 - 11:30: Session 05: Impact of sperm function on reproductive outcome:
Alberto Pacheco Castro, Spain
Chairperson to be announced
10:00 - 10:15
Oocyte quality modulates the impact of paternal age on ICSI outcomes: novel insights from an AI-based oocyte scoring system
Edson Borges Junior, Brazil
10:15 - 10:30
Seminal oxidative stress is associated with reduced fertilisation and blastocyst rates in donor-oocyte ICSI cycles, but not in donor-oocyte IVF cycles
10:30 - 10:45
Assessment of dsDNA breaks as a proxy for predicting embryo development and aneuploidy
Angela Bryanne De Jesus, U.S.A.
10:45 - 11:00
Advanced paternal age associates with lower blastocyst rate and reduced cumulative live birth rate. Clinical results from 1,021 egg donation cycles
Maurizio De Rocco Ponce, Spain
11:00 - 11:15
High sperm DNA fragmentation is associated with higher chromosome abnormality rates: a retrospective study involving 5637 couples
11:15 - 11:30
Integrating AI-driven hyperspectral sperm imaging for prioritisation of spermatozoa associated with embryo implantation
Rosa María Pacheco-Rendón, Spain
10:00 - 11:30
Session 06: Advances in embryo aneuploidy assessment
10:00 - 11:30: Session 06: Advances in embryo aneuploidy assessment:
Christian Simon Ottolini, Italy
Chairperson to be announced
10:00 - 10:15
Paired trophectoderm and ICM analysis redefines segmental aneuploidy and embryo usability in poor-prognosis IVF patients
Balsam Al Hashimi, United Kingdom
10:15 - 10:30
Ten years of multicenter registry data on embryo transfers with uniform whole-chromosome and segmental aneuploidies
10:30 - 10:45
Chromosomal complexity correlates to AI-driven embryo scores across aneuploidy subtypes in PGT-A blastocysts
Monica Cremades Rodelgo, Spain
10:45 - 11:00
The complex landscape of segmental aneuploidy across 250,000 preimplantation embryos
Leoni Xanthopoulou, United Kingdom
11:00 - 11:15
Clinical outcomes following non-invasive preimplantation genetic testing in IVF: A systematic review and meta-analysis
Arya Nair Kovilveettil, United Kingdom
11:15 - 11:30
To re-biopsy or not? Diagnostic and clinical implications of segmental abnormalities detected by PGT-A
10:00 - 11:30
Session 07: Fertility preservation across the life span
10:00 - 11:30: Session 07: Fertility preservation across the life span:
Claudia Massarotti, Italy
Richard Anderson, United Kingdom
10:00 - 10:15
Long-term reproductive outcomes in survivors of childhood and adolescent cancer: a population-based study using linkage of national registers
Mausumi Das, United Kingdom
10:15 - 10:30
Age-related outcomes after planned oocyte cryopreservation: a 12-year national cohort study of over 12,000 cycles
10:30 - 10:45
Restoring fertility after gonadotoxic treatment: first successful autologous transplant of immature cryopreserved testicular tissue in the human
10:45 - 11:00
Are Women Cryopreserving Enough Oocytes for Fertility-Preservation? A Probabilistic Model Integrating Artificial Intelligence (AI)-Based Oocyte Morphology and Age-Dependent Euploidy
11:00 - 11:15
Gender Affirming Hormone Treatment (GHAT) at referral and fertility preservation outcomes in Transgender and Gender-Diverse (TGD) patients: an NHS cohort study
Orestis Tsonis, United Kingdom
11:15 - 11:30
Impact of chemotherapy on ovarian reserve in premenopausal women with breast cancer treated with and without ovarian tissue cryopreservation for fertility preservation: a cohort study
10:00 - 11:30
Session 08: Poster discussion session - Safety and Quality in ART
10:00 - 11:30: Session 08: Poster discussion session - Safety and Quality in ART:
10:00 - 10:10
Mediation by multifetal births on risk of congenital anomalies after fertility treatment: a population-based cohort study
10:10 - 10:20
Live birth rate of women with different duration of estradiol supplementation in HRT cycles for frozen embryo transfer: a prospective, randomized, controlled, non-inferiority study
10:20 - 10:30
Ovarian Response Prediction Index (ORPI) as a practical quality and safety tool in routine ART stimulation: a real‑world study
Bianca Campos Matuella, Brazil
10:30 - 10:40
Upper secondary school achievement in young adults born after assisted reproductive technology (ART)- a national register-based cohort study
10:40 - 10:50
Measuring what matters in IVF: a mathematical modelling of why commonly reported success metrics fail to reflect patient-centred outcomes and what should we measure instead
Cristina Hickman, United Kingdom
10:50 - 11:00
Effect of gamete and embryo handling techniques on microbial presence in ICSI cycles
11:00 - 11:10
Reproductive Outcomes of Different Management Approaches for Cesarean Scar–Associated Intrauterine Fluid Accumulation in Frozen Embryo Transfer Cycles
Giang Duong Thi Tra, Vietnam
11:10 - 11:20
The role of offspring genetics in fetal and placental growth differences following frozen embryo transfer, fresh embryo transfer and natural conception
Anna Sophie Lebech Kjaer, Denmark
11:20 - 11:30
Morphometric consequences of blastocyst manipulations: size reduction and lower re-expansion after warming without impact on live-birth.
11:45 - 12:45
Session 09: Unlocking the secrets of the zona pellucida
11:45 - 12:45: Session 09: Unlocking the secrets of the zona pellucida:
Martin Wilding, United Kingdom
11:45 - 12:05
Unraveling the egg coat architecture and how ZP2 cleavage ensures the polyspermy block
12:15 - 12:35
Decoding the zona pellucida: unimagined features revealed by protein-targeting reverse genetics
11:45 - 12:45
Session 10: ESHRE's PGT Consortium and FerGI data reports
11:45 - 12:45: Session 10: ESHRE's PGT Consortium and FerGI data reports:
Chairperson to be announced
Joyce Harper, United Kingdom
11:45 - 12:15
Data from the ESHRE PGT Consortium - year 2024
Eftychia Dimitriadou, Belgium
12:15 - 12:45
Defining cut-off values in oocyte, zygote, and embryo maturation arrest (OZEMA)
11:45 - 12:45
Session 11: ASRM exchange session: Impact of health optimisation on reproductive outcomes
11:45 - 12:45: Session 11: ASRM exchange session: Impact of health optimisation on reproductive outcomes:
Robert E. Brannigan, U.S.A.
11:50 - 12:05
Lifestyle, metabolism, and male reproduction: an integrated approach to optimising male fertility
Robert E. Brannigan, U.S.A.
12:05 - 12:20
Gametes and embryos - biological archives, reflecting patients’ lifestyles
12:20 - 12:35
Lifestyle factors affecting female fertility: what can be improved?
11:45 - 12:45
Session 12: Mimicking the human embryonic- endometrial dialogue In vitro
11:45 - 12:45: Session 12: Mimicking the human embryonic- endometrial dialogue In vitro:
Chairperson to be announced
Chairperson to be announced
11:45 - 12:05
Modelling the embryo
Joshua Mark Brickman, Denmark
12:15 - 12:35
Modelling the endometrium
11:45 - 12:45
Session 13: Live journal club: Four decades of breakthroughs in human reproduction
11:45 - 12:45: Session 13: Live journal club: Four decades of breakthroughs in human reproduction:
11:47 - 11:52
ESHRE JC intro 40 years of human reproduction
Kirstine Kirkegaard, Denmark
Paper presentations and expert opinions
11:52 - 11:57
1980’s - Embryo metabolism article
11:57 - 12:01
Expert discussion
Roger Sturmey, United Kingdom
12:01 - 12:06
1990’s - ICSI in clinical outcomes article
Dimitrios-Rafail Kalaitzopoulos, Switzerland
12:06 - 12:10
Expert discussion
Chris Barratt, United Kingdom
12:10 - 12:15
2000’s - Fertility preservation ovarian tissue article
12:15 - 12:19
Expert discussion
Christiani Amorim, Belgium
12:19 - 12:24
2010’s Number of oocytes to maximize CLBR article
12:24 - 12:28
Expert discussion
12:28 - 12:33
2020’s ovarian aging and oxidative damage article
12:33 - 12:37
Expert discussion
12:37 - 12:42
Closing & takeaways - Experts and EIC
12:42 - 12:45
Final thanks
11:45 - 12:45
Session 14: Poster discussion session - Reproductive Endocrinology
11:45 - 12:45: Session 14: Poster discussion session - Reproductive Endocrinology:
11:45 - 11:55
Women's reproductive health: multimorbidity patterns and longitudinal disease trajectories in a population-based cohort of 2 million women
11:55 - 12:05
A family-building perspective in IVF: the contribution of each additional oocyte to cumulative live birth rate
12:05 - 12:15
Intrinsic Variability of Follicular Recruitment in Poor-Prognosis Patients Under Repeated Stimulation
Jonalyn De Vera Edades, United Arab Emirates
12:15 - 12:25
Oral Linzagolix for ovulation suppression during controlled ovarian stimulation compared with standard injectable GnRH antagonists in IVF cycles: a retrospective matched case–control study.
12:25 - 12:35
Clinical outcomes using an oral-antagonist of GnRH in IVF Cycles: A Retrospective Matched Case–Control Study
12:35 - 12:45
A single intra-ovarian platelet-rich plasma (PRP) injection is not associated with increased oocyte yield in women with low ovarian reserve: a randomised controlled trial
Tanja Maier-Eggersmann, Germany
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:00
Session 15: Debate: Back to basics or back to the future?
14:00 - 15:00: Session 15: Debate: Back to basics or back to the future?:
Dagan Wells, United Kingdom
14:00 - 14:15
Back to basics: is polar body-based PGT-A still relevant?
Michael Feichtinger, Austria
14:15 - 14:30
Back to the future: the promise of whole genome sequencing in human embryos
Michael Feichtinger, Austria
14:00 - 15:00
Session 16: Updated POI guideline symposium: advances and practical aspects
14:00 - 15:00: Session 16: Updated POI guideline symposium: advances and practical aspects:
Amanda Vincent, Australia
Chairperson to be announced
14:00 - 14:20
Diagnosis and fertility aspects of POI
Richard Anderson, United Kingdom
14:30 - 14:50
Genetics of POI: a leap for diagnosis and personalized medicine in new guidelines
Micheline Misrahi, France
14:00 - 15:00
Session 17: FSANZ exchange session
14:00 - 15:00: Session 17: FSANZ exchange session:
Alison Campbell, United Kingdom
14:00 - 14:20
Embryos can self-correct: ejection of abnormally cleaving cells is associated with higher live birth rates
14:00 - 15:00
Session 18: Emerging regenerative strategies for gamete and ovarian function in ART
14:00 - 15:00: Session 18: Emerging regenerative strategies for gamete and ovarian function in ART:
Francesca Gioia Klinger, Italy
Varsha Jain, United Kingdom
14:00 - 14:15
Evaluating the efficacy of intraovarian HucMSC-exosome treatment vs PRP: advancing follicular reactivation in women of advanced maternal age
Ulyana Dorofeyeva, Ukraine
14:15 - 14:30
Tubal extracellular vesicles from human fallopian tubes and derived organoids promote the maintenance of sperm fertilising capacity.
14:30 - 14:45
Mouse embryonic stem cell-derived exosomes rejuvenates oocyte quality by enhancing mitochondria during female reproductive aging
14:45 - 15:00
Intraovarian platelet-rich plasma in poor ovarian reserve: does route of administration influence ovarian responsiveness and feasibility?
14:00 - 15:00
Session 19: IRHEC session: International Reproductive Health Education Collaboration (IRHEC) – An update
14:00 - 15:00: Session 19: IRHEC session: International Reproductive Health Education Collaboration (IRHEC) – An update:
Bola Grace, United Kingdom
14:00 - 14:20
IRHEC update
Maria Ekstrand Ragnar, Sweden
14:30 - 14:50
Community awareness of pregnancy preparation and preconception health
Danielle Schoenaker, United Kingdom
14:00 - 15:00
Session 20: Poster discussion session - Fertility Preservation
14:00 - 15:00: Session 20: Poster discussion session - Fertility Preservation:
Moderator to be announced
14:00 - 14:10
Return rates and cumulative live birth rates following the use of oocytes after elective oocyte cryopreservation. 12 years’ experience .
Miguel Solé Inarejos, Spain
14:10 - 14:20
Oocyte-secreted protein 2 enhances in vitro maturation of ovarian tissue oocytes for fertility preservation via cumulus-oocyte crosstalk
14:20 - 14:30
Serum progesterone concentration in women undergoing progestin-primed ovarian stimulation for fertility preservation before oncological treatments
14:30 - 14:40
In Vitro Growth of human primordial follicles: Effect of Trigonelline hydrochloride on follicle activation and growth
AHMED AJLAN, United Kingdom
14:40 - 14:50
Fertility preservation and recurrence risk in women with borderline and malignant ovarian tumours: a single tertiary centre experience.
Lucrezia Viola De Braud, United Kingdom
14:50 - 15:00
Fertility preservation and reproductive outcomes in females with haemoglobinopathies: a systematic review and meta-analysis
Katrina Sherlock, United Kingdom
15:15 - 16:30
Session 21: Rewriting embryo selection through hidden signals
15:15 - 16:30: Session 21: Rewriting embryo selection through hidden signals:
Maria Jose De Los Santos, Spain
Bryan Woodward, United Kingdom
15:15 - 15:30
Blastocoel fluid RNA predicts pregnancy outcome in assisted reproduction
Caroline Frisendahl, Sweden
15:30 - 15:45
Different secretome profiles characterize euploid and aneuploid human embryos cultured up to 14 days in advanced 3D endometrial co-culture.
Roberto Yagüe Serrano, Spain
15:45 - 16:00
Cytoplasmic speed in oocytes and embryos as a marker of developmental potential: stage-specific analyses offer distinct insights.
16:00 - 16:15
Post-warming cfDNA release as a marker of implantation and live birth in frozen embryo transfer
16:15 - 16:30
Selection of single euploid blastocysts with cytoplasmic strings for transfer improved clinical outcomes for patients undergoing preimplantation genetic testing for aneuploid: a prospective clinical study
15:15 - 16:30
Session 22: Unraveling the endometrial microenvironment: immune, spatial, and transcriptomic insights across uterine disorders
15:15 - 16:30: Session 22: Unraveling the endometrial microenvironment: immune, spatial, and transcriptomic insights across uterine disorders:
Chairperson to be announced
15:15 - 15:30
Integrated single-cell RNA-sequencing and cytokine profiling reveal a systemic inflammatory and fibrotic landscape across lesions, endometrium, and menstrual blood in adenomyosis.
15:30 - 15:45
A spatial atlas of the human fallopian tube across the menstrual cycle reveals complement-driven epithelial-immune crosstalk
15:45 - 16:00
Predictors of satisfaction regarding hormonal therapy use in women with endometriosis and/or adenomyosis: Dutch results from the international TEPEA-study
Robin de Jong, The Netherlands
16:00 - 16:15
Endometrial immune profiling identifies a transcriptomic signature of implantation failure that is specifically mitigated by adjuvant G-CSF administration
16:15 - 16:30
Menstrual cycle–dependent spatial-omics heterogeneity in uterine fibroids and adjacent myometrium
Lorna Salvini, United Kingdom
15:15 - 16:30
Session 23: Systemic drivers of male infertility
15:15 - 16:30: Session 23: Systemic drivers of male infertility:
Chairperson to be announced
Chairperson to be announced
15:15 - 15:30
Male infertility and risk of cancers: a population-based cohort study in New South Wales, Australia
15:30 - 15:45
Gut-testis axis drives testicular inflammation, aging, and spermatogenesis impairment
Philip C.N. Chiu, Hong Kong
15:45 - 16:00
LRRC46 defines an IFT/IMT-dependent assembly checkpoint linking asthenoteratozoospermia and high myopia
16:00 - 16:15
Three sources of signals: how extracellular vesicles from the follicular fluid, seminal plasma and mesenchymal stem cells differentially influence male gametes
Sysoeva Anastasiya, Russia C.I.S.
16:15 - 16:30
Single-cell transcriptomic landscape of spermatogenic abnormalities in diabetes
15:15 - 16:30
Session 24: Hidden determinants of success in ART
15:15 - 16:30: Session 24: Hidden determinants of success in ART:
Nicholas Macklon, United Kingdom
15:15 - 15:30
Risk of endometriosis, adenomyosis and related symptoms among women conceived by mothers on hormonal contraceptives
15:30 - 15:45
What drives cumulative live birth in IVF? Insights from a cohort study in LMIC
Georges Abi Tayeh, Lebanon
15:45 - 16:00
Bridging the knowledge-to-action gap: formal training as the primary driver of fertility preservation referrals. Across-sectional study
raneen sawaid kaiyal, Israel
16:00 - 16:15
Reframing fertility awareness: who, why and how? A call for novel approaches to improving reproductive health education
Amelia Peterson, United Kingdom
16:15 - 16:30
Impact of waitlist duration on pregnancy outcomes in assisted reproduction: prognostic value of age and related parameters in a spanish public IVF program
César Lizán Tudela, Spain
15:15 - 16:30
Session 25: Determinants and interventions for short term outcome
15:15 - 16:30: Session 25: Determinants and interventions for short term outcome:
Gorka Barrenetxea Ziarrusta, Spain
Chairperson to be announced
15:15 - 15:30
Impact of conception method and endometrial preparation on first-trimester uterine artery Doppler and pre-eclampsia screening: a large retrospective cohort study
15:30 - 15:45
Fetal growth trajectories after conception with medically assisted reproduction – a nationwide cohort study
15:45 - 16:00
Age limits for safe pregnancy in oocyte donation: evaluating the increased incidence of maternal and neonatal complications beyond natural reproductive limits
Maria Volotovskaya, Italy
16:00 - 16:15
Progesterone luteal-phase support (LPS) in modified natural cycle frozen embryo transfer (mNC-FET) among women of advanced reproductive age or low ovarian reserve
Amalie Somuncu Johansen, Denmark
16:15 - 16:30
Preconception GLP-1 receptor agonist exposure in couples and fertility outcomes: a danish nationwide cohort study
15:15 - 16:30
Session 26: Psychological impact on medically assisted reproduction
15:15 - 16:30: Session 26: Psychological impact on medically assisted reproduction:
Verena Ehrbar, Switzerland
Jacky Boivin, United Kingdom
15:15 - 15:30
Distinct dyadic trajectories of depression and anxiety in couples undergoing medically assisted reproduction (MAR): A 2-year latent class growth analysis
Katherine Péloquin, Canada
15:30 - 15:45
Overestimation of anxiety, depression and eating disorders in women with PCOS
Tamara Jannink, The Netherlands
15:45 - 16:00
In vitro fertilisation and new-onset mental illness
Dalia Limor Karol, Canada
16:00 - 16:15
Psychological resilience in men from couples undergoing intracytoplasmic sperm injection (ICSI) is associated with blastocyst quality: a prospective study
16:15 - 16:30
Psychological impact of pregnancy loss before 24 weeks across time and income settings: an umbrella review
Joshua Odendaal, United Kingdom
15:15 - 16:25
Session 27: Poster discussion session - Psychology and Counselling
15:15 - 16:25: Session 27: Poster discussion session - Psychology and Counselling:
Moderator to be announced
15:15 - 15:25
The invisible laboratory: limited embryologist contact and its association with understanding, anxiety and continuity of IVF care—national survey of 1,829 women
Ignacio Moreno, Argentina
15:25 - 15:35
Short-term and long-term implications of insemination fraud as experienced by donor-conceived people and parents and their needs for psychosocial support: a qualitative study.
15:35 - 15:45
Psychological screening of gamete donors: sociodemographic factors and the complementary role of clinical interview beyond a psychopathological screening test
15:45 - 15:55
The potential relationship between psychological distress, psychophysiological stress, and ART outcomes
Margarida Silva, Portugal
15:55 - 16:05
Treatment discontinuation in IVF: an in-depth characterization across different settings
16:05 - 16:15
Exploring donor-conceived individuals’ experiences of donor sibling relationships: A systematic review and thematic synthesis
Ulrik Schiøler Kesmodel, Denmark
16:15 - 16:25
Sexuality-related outcomes in infertility: an umbrella review of systematic reviews and meta-analyses
16:30 - 17:00
Coffee break
16:30 - 17:00: Coffee break:
17:00 - 18:00
Session 28: Modelling of endometriosis and endometrial disorders
17:00 - 18:00: Session 28: Modelling of endometriosis and endometrial disorders:
Christian Becker, United Kingdom
17:00 - 17:20
Complex in vitro 3D modelling of endometriosis and endometrial disorders
Christopher Hill, United Kingdom
17:30 - 17:50
Advances in bioengineering research in endometrial disorders
Irene Cervelló Alcaraz, Spain
17:00 - 18:00
Session 29: Semen analysis: a revisit
17:00 - 18:00: Session 29: Semen analysis: a revisit:
Chairperson to be announced
17:00 - 17:20
Semen analysis: how does it help in predicting and managing infertility?
Nicolás Garrido Puchalt, Spain
17:30 - 17:50
Human sperm function testing - useful or useless
Chris Barratt, United Kingdom
17:00 - 18:00
Session 30: Changes in uterine function after cesarean delivery
17:00 - 18:00: Session 30: Changes in uterine function after cesarean delivery:
Mohamed Mabrouk, United Kingdom
17:00 - 17:20
Repairing isthmocele in infertile patients
17:30 - 17:50
Uterine inflammatory characteristics following CS
17:00 - 18:00
Session 31: Advancing fertility care: Integrating innovation, patient experience and professional competence
17:00 - 18:00: Session 31: Advancing fertility care: Integrating innovation, patient experience and professional competence:
Chairperson to be announced
Manuela Perrotta, United Kingdom
17:00 - 17:15
Beyond ESHRE certification: skills, knowledge, competence, and career progression of nurses and midwives working in reproductive medicine
17:15 - 17:30
Development of an impact scale for men experiencing infertility problems
17:30 - 17:45
Beyond medical treatment: addressing the emotional and spiritual dimensions of infertility – a mixed-methods approach
Madeleine Bernet, Switzerland
17:45 - 18:00
Virtual reality is a feasible, effective, and safe intervention for reducing pain and anxiety during oocyte retrieval: a randomised controlled trial
17:00 - 18:00
Session 32: Guidelines session: Setting the standard: from carrier screening to the IVF laboratory
17:00 - 18:00: Session 32: Guidelines session: Setting the standard: from carrier screening to the IVF laboratory:
Dhruti Babariya, United Kingdom
17:00 - 17:20
Good practice recommendations on ECS: who, when and how?
17:30 - 17:50
Update of the recommendations for good practice in the IVF lab: what has changed?
Ioannis Sfontouris, Greece
17:00 - 18:00
Session 33: Poster discussion session - Global and Socio-cultural Aspects of Infertility
17:00 - 18:00: Session 33: Poster discussion session - Global and Socio-cultural Aspects of Infertility:
Chairperson to be announced
17:00 - 17:10
Evolution of ART in Italy: analysis of 1.8 million cycles over 20 years from the Italian ART Registry
17:10 - 17:20
Reproductive outcomes after elective oocyte cryopreservation: a 10-year epidemiological follow-up study of 17,122 cryopreserved oocytes in Latin America.
Marcello Pereira Valle, Brazil
17:20 - 17:30
Ambient Air Pollution (PM2.5) and ART Outcomes in Europe: A Cross-Continental Comparison with North America and East Asia
Jeffrey Zi Kang Huang, Taiwan R.O.C.
17:30 - 17:40
The BMI curve for reproductive success: identifying the optimal and safe zone in 16000+ IVF cycles
17:40 - 17:50
Misinformation or Medicine? Assessing the accuracy of contraceptive claims on social media: A cross-sectional content analysis
Charlotte Simms, United Kingdom
17:50 - 18:00
Reproductive governance in practice: A qualitative study of how HFEA regulatory frameworks structure clinical decision-making and donor availability in United Kingdom egg donation.